Another study suggested that α-Hederin reversed cisplatin resistance in NSCLC by silencing SLC7A11 and inhibiting miR-96-5p, activating DDIT3/ATF3-mediated ferroptosis [86]. The gene discussed is DDIT3; the disease is non-small cell lung carcinoma.